Skip to content

The Comparison of Hemodynamic Effects Between Remimazolam-remifentanil and Propofol-remifentanil in Patients Undergoing Laparoscopic Cholecystectomy

The Comparison of Hemodynamic Effects Between Remimazolam-remifentanil and Propofol-remifentanil in Patients Undergoing Laparoscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05164159
Enrollment
274
Registered
2021-12-20
Start date
2022-02-20
Completion date
2022-08-22
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis

Brief summary

This study is conducted to determine whether the occurrence of hypotension is reduced by the combined use of remimazolam and remifentanil compared to the conventional combination use of propofol and remifentanil. Patients enrolled in the study are infused continuously with either propofol or remimazolam from the start of anesthesia to the end of surgery.

Interventions

DRUGpropofol group

During induction, the propofol group starts the effect site concentration at 4.0 ng/ml with TCI and adjusts it to around 3.0 \ 4.0 ng/ml after intubation to maintain an appropriate EEG-based depth of anesthesia.

In the remimazolam group, start remimazolam at 6 mg/kg/hr and adjust it to 1 mg/kg/hr after loss of consciousness to maintain an appropriate EEG-based depth of anesthesia.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

1. patients 19 years of age or older 2. the American Society of Anesthesiologists classification 1-3 3. patients undergoing laparoscopic cholecystectomy at Severance Hospital

Exclusion criteria

1. Emergency surgery, 2. patients with heart disease or arrhythmias, 3. patients undergoing concurrent surgery other than laparoscopic cholecystectomy, 4. obesity (BMI\>30), 5. patients who were admitted on the surgery day, 6. foreigners, 7. illiteracy

Design outcomes

Primary

MeasureTime frame
Percent of patients with hypotension eventfrom start of drugs to end of anesthesia on the surgery 1 day

Secondary

MeasureTime frameDescription
time-weighted average of hypotensionfrom start of drugs to end of anesthesia on the surgery 1 daytime-weighted average of hypotension is calculated as the depth of hypotension below a MAP of 65 mm Hg (in millimeters of mercury) × time spent below a MAP of 65 mm Hg (in minutes) divided by total duration of operation (in minutes).
dose of Norepinephrine or nicardipinefrom start of drugs to end of anesthesia on the surgery 1 day
difference of QOR-40 scoreBaseline (preoperative period) and Postoperative day 1QoR-40 was developed by Myles et al and is a questionnaire that can examine the quality of recovery and health status of patients in the early postoperative period. Patients will also fill out a questionnaire before surgery for comparison with postoperative scores.
Heart rate variabilityfrom start of drugs to end of anesthesia on the surgery 1 dayHeart rate variability is a relatively easy and non-invasive measurement method that reflects the level of balance between the sympathetic and parasympathetic nerves at every moment using EKG records.
Sedline(Psi)from start of drugs to end of anesthesia on the surgery 1 day

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026